ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 70 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 3.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,966 | -13.3% | 40,322 | +8.0% | 0.00% | – |
| Q2 2023 | $139,573 | -27.2% | 37,319 | -34.8% | 0.00% | – |
| Q1 2023 | $191,641 | +26.5% | 57,206 | +81.7% | 0.00% | – |
| Q4 2022 | $151,438 | -14.0% | 31,484 | +1.6% | 0.00% | – |
| Q3 2022 | $176,000 | -90.7% | 30,974 | -88.4% | 0.00% | -100.0% |
| Q2 2022 | $1,892,000 | +6.2% | 266,578 | +8.0% | 0.00% | 0.0% |
| Q1 2022 | $1,782,000 | +172.5% | 246,794 | +237.1% | 0.00% | – |
| Q4 2021 | $654,000 | -80.1% | 73,215 | -22.0% | 0.00% | -100.0% |
| Q3 2021 | $3,293,000 | +295.3% | 93,907 | +142.3% | 0.00% | – |
| Q2 2021 | $833,000 | +38.8% | 38,757 | +299.2% | 0.00% | – |
| Q1 2021 | $600,000 | +35.4% | 9,709 | -8.4% | 0.00% | – |
| Q4 2020 | $443,000 | – | 10,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |